FDA halts new clinical trials that export Americans cells to foreign labs in hostile countries for genetic engineering

Niaid.nih.gov

Click here to subscribe to Niaid.nih.gov

14 days ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

FDA halts new clinical trials that export Americansâ cells to foreign labs in hostile countries for genetic engineering
Trials failed to inform participants about the international transfer.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourÂ Frequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHâ¦Turning Discovery Into HealthÂ®Â

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) Â· 9000 Rockville Pike Â· Bethesda MD 20892 Â· 301-496-4000 / TTY 301-402-9612

Share on

Other newsletters from Niaid.nih.gov

CMS Coverage Email Updates Niaid.nih.gov
14 hours ago
NIH study links particulate air pollution to inc reased mutations in lung cancers among nonsmokers Niaid.nih.gov
18 hours ago
Breast cancer risk in younger women may be influenced by hormone therapy Niaid.nih.gov
Last Monday at 23:50

More newsletters from Niaid.nih.gov

FDA halts new clinical trials that export Americans cells to foreign labs in hostile countries for genetic engineering

Share on

Other newsletters from Niaid.nih.gov

Related newsletters